CD34 and neoplasm: Tumours treated with either nsPEFs alone or everolimus alone exhibited decreased VEGF, VEGFR, and CD34 expression, while the combined treatment showed an increased inhibition of VEGF, VEGFR, and CD34 expression, indicating that nsPEFs and everolimus synergistically suppressed neovascular growth.